Cointime

TwinStrand Biosciences

company

About

TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.

  • 51 - 100

Highlights

Total Funding Amount
$5.28M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$5.28M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics.

TwinStrand Biosciences holds an exclusive worldwide license to develop and commercialize Duplex Sequencing. It was founded in 2015 and is headquartered in Bellevue, Washington.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.28M
TwinStrand Biosciences has raised a total of $5.28M in funding over 2 rounds. Their latest funding was raised on Sep 13, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 13, 2017 Series Unknown $5.28M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
TwinStrand Biosciences is funded by 1 investors. Reference Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Reference Capital — Series Unknown
Cointime
เนื้อหา
บริษัท